FAS functions as an apoptosis receptor for oligodendrocytes 2, 14, 65, therefore, higher FAS expression may make oligodendrocytes more likely to undergo apoptosis and thus more vulnerable to the MS disease process. This evidence concerns the gene FAS and myeloid sarcoma.